UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000020681 |
|---|---|
| Receipt number | R000023796 |
| Scientific Title | Randomized open-label phase II study of adjuvant chemotherapy of S-1 plus metformin vs. S-1 alone in patients with resected pancreatic cancer |
| Date of disclosure of the study information | 2016/01/22 |
| Last modified on | 2023/07/27 14:10:16 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/01/21 15:30:44 | ||
| 2 | Update | 2016/01/29 11:18:22 | Interventions/Control_1 Interventions/Control_2 |
|
| 3 | Update | 2016/01/29 11:25:39 | Acronym Acronym |
|
| 4 | Update | 2016/01/29 15:11:32 | Interventions/Control_1 Interventions/Control_2 |
|
| 5 | Update | 2017/01/24 10:30:24 | Key secondary outcomes Key secondary outcomes |
|
| 6 | Update | 2017/01/24 11:35:25 | Interventions/Control_1 Interventions/Control_2 Key inclusion criteria Key exclusion criteria |
|
| 7 | Update | 2017/01/24 11:45:03 | Name of primary person or sponsor Organization |
|
| 8 | Update | 2017/08/17 10:37:37 | Interventions/Control_1 Interventions/Control_2 Key inclusion criteria Key exclusion criteria |
|
| 9 | Update | 2018/08/27 14:09:03 | Key inclusion criteria Key inclusion criteria |
|
| 10 | Update | 2018/08/27 14:12:26 | Recruitment status Anticipated trial start date Last follow-up date |
|
| 11 | Update | 2019/07/25 15:29:24 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization1 Email1 Organization Organization Address Address Tel Institutions |
|
| 12 | Update | 2019/07/25 15:39:46 | Date of IRB |
|
| 13 | Update | 2021/08/13 09:59:38 | Organization1 Address1 Tel1 Email1 Organization Organization Address Address Tel Institutions |
|
| 14 | Update | 2022/01/31 14:28:33 | Recruitment status Last follow-up date |
|
| 15 | Update | 2022/01/31 14:35:41 | Number of participants that the trial has enrolled |
|
| 16 | Update | 2022/07/28 10:53:53 | Institutions |
|
| 17 | Update | 2023/01/27 13:35:19 | Institutions |
|
| 18 | Update | 2023/07/27 14:10:16 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator |
